Global Diagnostic Nuclear Drug Market Size, Status and Forecast 2024-2031

Report ID: 922390 | Published Date: Sep 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Tc-99m
        1.2.3 F-18
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Diagnostic Nuclear Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Oncology
        1.3.3 Cardiology
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Diagnostic Nuclear Drug Market Perspective (2016-2027)
    2.2 Diagnostic Nuclear Drug Growth Trends by Regions
        2.2.1 Diagnostic Nuclear Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Diagnostic Nuclear Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Diagnostic Nuclear Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Diagnostic Nuclear Drug Industry Dynamic
        2.3.1 Diagnostic Nuclear Drug Market Trends
        2.3.2 Diagnostic Nuclear Drug Market Drivers
        2.3.3 Diagnostic Nuclear Drug Market Challenges
        2.3.4 Diagnostic Nuclear Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Diagnostic Nuclear Drug Players by Revenue
        3.1.1 Global Top Diagnostic Nuclear Drug Players by Revenue (2016-2021)
        3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Diagnostic Nuclear Drug Revenue
    3.4 Global Diagnostic Nuclear Drug Market Concentration Ratio
        3.4.1 Global Diagnostic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Drug Revenue in 2020
    3.5 Diagnostic Nuclear Drug Key Players Head office and Area Served
    3.6 Key Players Diagnostic Nuclear Drug Product Solution and Service
    3.7 Date of Enter into Diagnostic Nuclear Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Nuclear Drug Breakdown Data by Type
    4.1 Global Diagnostic Nuclear Drug Historic Market Size by Type (2016-2021)
    4.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2022-2027)

5 Diagnostic Nuclear Drug Breakdown Data by Application
    5.1 Global Diagnostic Nuclear Drug Historic Market Size by Application (2016-2021)
    5.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Diagnostic Nuclear Drug Market Size (2016-2027)
    6.2 North America Diagnostic Nuclear Drug Market Size by Type
        6.2.1 North America Diagnostic Nuclear Drug Market Size by Type (2016-2021)
        6.2.2 North America Diagnostic Nuclear Drug Market Size by Type (2022-2027)
        6.2.3 North America Diagnostic Nuclear Drug Market Size by Type (2016-2027)
    6.3 North America Diagnostic Nuclear Drug Market Size by Application
        6.3.1 North America Diagnostic Nuclear Drug Market Size by Application (2016-2021)
        6.3.2 North America Diagnostic Nuclear Drug Market Size by Application (2022-2027)
        6.3.3 North America Diagnostic Nuclear Drug Market Size by Application (2016-2027)
    6.4 North America Diagnostic Nuclear Drug Market Size by Country
        6.4.1 North America Diagnostic Nuclear Drug Market Size by Country (2016-2021)
        6.4.2 North America Diagnostic Nuclear Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Diagnostic Nuclear Drug Market Size (2016-2027)
    7.2 Europe Diagnostic Nuclear Drug Market Size by Type
        7.2.1 Europe Diagnostic Nuclear Drug Market Size by Type (2016-2021)
        7.2.2 Europe Diagnostic Nuclear Drug Market Size by Type (2022-2027)
        7.2.3 Europe Diagnostic Nuclear Drug Market Size by Type (2016-2027)
    7.3 Europe Diagnostic Nuclear Drug Market Size by Application
        7.3.1 Europe Diagnostic Nuclear Drug Market Size by Application (2016-2021)
        7.3.2 Europe Diagnostic Nuclear Drug Market Size by Application (2022-2027)
        7.3.3 Europe Diagnostic Nuclear Drug Market Size by Application (2016-2027)
    7.4 Europe Diagnostic Nuclear Drug Market Size by Country
        7.4.1 Europe Diagnostic Nuclear Drug Market Size by Country (2016-2021)
        7.4.2 Europe Diagnostic Nuclear Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Diagnostic Nuclear Drug Market Size (2016-2027)
    8.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type
        8.2.1 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application
        8.3.1 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region
        8.4.1 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Diagnostic Nuclear Drug Market Size (2016-2027)
    9.2 Latin America Diagnostic Nuclear Drug Market Size by Type
        9.2.1 Latin America Diagnostic Nuclear Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Diagnostic Nuclear Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Diagnostic Nuclear Drug Market Size by Type (2016-2027)
    9.3 Latin America Diagnostic Nuclear Drug Market Size by Application
        9.3.1 Latin America Diagnostic Nuclear Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Diagnostic Nuclear Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Diagnostic Nuclear Drug Market Size by Application (2016-2027)
    9.4 Latin America Diagnostic Nuclear Drug Market Size by Country
        9.4.1 Latin America Diagnostic Nuclear Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Diagnostic Nuclear Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Diagnostic Nuclear Drug Market Size (2016-2027)
    10.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type
        10.2.1 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application
        10.3.1 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country
        10.4.1 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Bracco Imaging
        11.1.1 Bracco Imaging Company Details
        11.1.2 Bracco Imaging Business Overview
        11.1.3 Bracco Imaging Diagnostic Nuclear Drug Introduction
        11.1.4 Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.1.5 Bracco Imaging Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Details
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Diagnostic Nuclear Drug Introduction
        11.2.4 Bayer Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.2.5 Bayer Recent Development
    11.3 Curium Pharmaceuticals
        11.3.1 Curium Pharmaceuticals Company Details
        11.3.2 Curium Pharmaceuticals Business Overview
        11.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Introduction
        11.3.4 Curium Pharmaceuticals Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.3.5 Curium Pharmaceuticals Recent Development
    11.4 Nordion
        11.4.1 Nordion Company Details
        11.4.2 Nordion Business Overview
        11.4.3 Nordion Diagnostic Nuclear Drug Introduction
        11.4.4 Nordion Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.4.5 Nordion Recent Development
    11.5 Triad Isotopes
        11.5.1 Triad Isotopes Company Details
        11.5.2 Triad Isotopes Business Overview
        11.5.3 Triad Isotopes Diagnostic Nuclear Drug Introduction
        11.5.4 Triad Isotopes Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.5.5 Triad Isotopes Recent Development
    11.6 Lantheus
        11.6.1 Lantheus Company Details
        11.6.2 Lantheus Business Overview
        11.6.3 Lantheus Diagnostic Nuclear Drug Introduction
        11.6.4 Lantheus Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.6.5 Lantheus Recent Development
    11.7 GE Healthcare
        11.7.1 GE Healthcare Company Details
        11.7.2 GE Healthcare Business Overview
        11.7.3 GE Healthcare Diagnostic Nuclear Drug Introduction
        11.7.4 GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.7.5 GE Healthcare Recent Development
    11.8 China Isotope & Radiation
        11.8.1 China Isotope & Radiation Company Details
        11.8.2 China Isotope & Radiation Business Overview
        11.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Introduction
        11.8.4 China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.8.5 China Isotope & Radiation Recent Development
    11.9 Jubilant Pharma
        11.9.1 Jubilant Pharma Company Details
        11.9.2 Jubilant Pharma Business Overview
        11.9.3 Jubilant Pharma Diagnostic Nuclear Drug Introduction
        11.9.4 Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.9.5 Jubilant Pharma Recent Development
    11.10 Eli Lilly
        11.10.1 Eli Lilly Company Details
        11.10.2 Eli Lilly Business Overview
        11.10.3 Eli Lilly Diagnostic Nuclear Drug Introduction
        11.10.4 Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.10.5 Eli Lilly Recent Development
    11.11 Novartis
        11.11.1 Novartis Company Details
        11.11.2 Novartis Business Overview
        11.11.3 Novartis Diagnostic Nuclear Drug Introduction
        11.11.4 Novartis Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.11.5 Novartis Recent Development
    11.12 SIEMENS
        11.12.1 SIEMENS Company Details
        11.12.2 SIEMENS Business Overview
        11.12.3 SIEMENS Diagnostic Nuclear Drug Introduction
        11.12.4 SIEMENS Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.12.5 SIEMENS Recent Development
    11.13 Dongcheng
        11.13.1 Dongcheng Company Details
        11.13.2 Dongcheng Business Overview
        11.13.3 Dongcheng Diagnostic Nuclear Drug Introduction
        11.13.4 Dongcheng Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.13.5 Dongcheng Recent Development
    11.14 Navidea
        11.14.1 Navidea Company Details
        11.14.2 Navidea Business Overview
        11.14.3 Navidea Diagnostic Nuclear Drug Introduction
        11.14.4 Navidea Revenue in Diagnostic Nuclear Drug Business (2016-2021)
        11.14.5 Navidea Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Diagnostic Nuclear Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Tc-99m
    Table 3. Key Players of F-18
    Table 4. Key Players of Other
    Table 5. Global Diagnostic Nuclear Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Diagnostic Nuclear Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Diagnostic Nuclear Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Diagnostic Nuclear Drug Market Share by Regions (2016-2021)
    Table 9. Global Diagnostic Nuclear Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Diagnostic Nuclear Drug Market Share by Regions (2022-2027)
    Table 11. Diagnostic Nuclear Drug Market Trends
    Table 12. Diagnostic Nuclear Drug Market Drivers
    Table 13. Diagnostic Nuclear Drug Market Challenges
    Table 14. Diagnostic Nuclear Drug Market Restraints
    Table 15. Global Diagnostic Nuclear Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Diagnostic Nuclear Drug Market Share by Players (2016-2021)
    Table 17. Global Top Diagnostic Nuclear Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Nuclear Drug as of 2020)
    Table 18. Ranking of Global Top Diagnostic Nuclear Drug Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Diagnostic Nuclear Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Diagnostic Nuclear Drug Product Solution and Service
    Table 22. Date of Enter into Diagnostic Nuclear Drug Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2016-2021)
    Table 26. Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Diagnostic Nuclear Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2016-2021)
    Table 30. Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Diagnostic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Diagnostic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Diagnostic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Diagnostic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Diagnostic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Diagnostic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Bracco Imaging Company Details
    Table 63. Bracco Imaging Business Overview
    Table 64. Bracco Imaging Diagnostic Nuclear Drug Product
    Table 65. Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 66. Bracco Imaging Recent Development
    Table 67. Bayer Company Details
    Table 68. Bayer Business Overview
    Table 69. Bayer Diagnostic Nuclear Drug Product
    Table 70. Bayer Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 71. Bayer Recent Development
    Table 72. Curium Pharmaceuticals Company Details
    Table 73. Curium Pharmaceuticals Business Overview
    Table 74. Curium Pharmaceuticals Diagnostic Nuclear Drug Product
    Table 75. Curium Pharmaceuticals Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 76. Curium Pharmaceuticals Recent Development
    Table 77. Nordion Company Details
    Table 78. Nordion Business Overview
    Table 79. Nordion Diagnostic Nuclear Drug Product
    Table 80. Nordion Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 81. Nordion Recent Development
    Table 82. Triad Isotopes Company Details
    Table 83. Triad Isotopes Business Overview
    Table 84. Triad Isotopes Diagnostic Nuclear Drug Product
    Table 85. Triad Isotopes Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 86. Triad Isotopes Recent Development
    Table 87. Lantheus Company Details
    Table 88. Lantheus Business Overview
    Table 89. Lantheus Diagnostic Nuclear Drug Product
    Table 90. Lantheus Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 91. Lantheus Recent Development
    Table 92. GE Healthcare Company Details
    Table 93. GE Healthcare Business Overview
    Table 94. GE Healthcare Diagnostic Nuclear Drug Product
    Table 95. GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 96. GE Healthcare Recent Development
    Table 97. China Isotope & Radiation Company Details
    Table 98. China Isotope & Radiation Business Overview
    Table 99. China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 100. China Isotope & Radiation Recent Development
    Table 101. Jubilant Pharma Company Details
    Table 102. Jubilant Pharma Business Overview
    Table 103. Jubilant Pharma Diagnostic Nuclear Drug Product
    Table 104. Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 105. Jubilant Pharma Recent Development
    Table 106. Eli Lilly Company Details
    Table 107. Eli Lilly Business Overview
    Table 108. Eli Lilly Diagnostic Nuclear Drug Product
    Table 109. Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 110. Eli Lilly Recent Development
    Table 111. Novartis Company Details
    Table 112. Novartis Business Overview
    Table 113. Novartis Diagnostic Nuclear Drug Product
    Table 114. Novartis Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 115. Novartis Recent Development
    Table 116. SIEMENS Company Details
    Table 117. SIEMENS Business Overview
    Table 118. SIEMENS Diagnostic Nuclear Drug Product
    Table 119. SIEMENS Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 120. SIEMENS Recent Development
    Table 121. Dongcheng Company Details
    Table 122. Dongcheng Business Overview
    Table 123. Dongcheng Diagnostic Nuclear Drug Product
    Table 124. Dongcheng Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 125. Dongcheng Recent Development
    Table 126. Navidea Company Details
    Table 127. Navidea Business Overview
    Table 128. Navidea Diagnostic Nuclear Drug Product
    Table 129. Navidea Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 130. Navidea Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diagnostic Nuclear Drug Market Share by Type: 2020 VS 2027
    Figure 2. Tc-99m Features
    Figure 3. F-18 Features
    Figure 4. Other Features
    Figure 5. Global Diagnostic Nuclear Drug Market Share by Application: 2020 VS 2027
    Figure 6. Oncology Case Studies
    Figure 7. Cardiology Case Studies
    Figure 8. Other Case Studies
    Figure 9. Diagnostic Nuclear Drug Report Years Considered
    Figure 10. Global Diagnostic Nuclear Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Diagnostic Nuclear Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Diagnostic Nuclear Drug Market Share by Regions: 2020 VS 2027
    Figure 13. Global Diagnostic Nuclear Drug Market Share by Regions (2022-2027)
    Figure 14. Global Diagnostic Nuclear Drug Market Share by Players in 2020
    Figure 15. Global Top Diagnostic Nuclear Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Nuclear Drug as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Diagnostic Nuclear Drug Revenue in 2020
    Figure 17. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2016-2021)
    Figure 18. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2022-2027)
    Figure 19. North America Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Diagnostic Nuclear Drug Market Share by Type (2016-2027)
    Figure 21. North America Diagnostic Nuclear Drug Market Share by Application (2016-2027)
    Figure 22. North America Diagnostic Nuclear Drug Market Share by Country (2016-2027)
    Figure 23. United States Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Diagnostic Nuclear Drug Market Share by Type (2016-2027)
    Figure 27. Europe Diagnostic Nuclear Drug Market Share by Application (2016-2027)
    Figure 28. Europe Diagnostic Nuclear Drug Market Share by Country (2016-2027)
    Figure 29. Germany Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Diagnostic Nuclear Drug Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Diagnostic Nuclear Drug Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Diagnostic Nuclear Drug Market Share by Region (2016-2027)
    Figure 39. China Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Diagnostic Nuclear Drug Market Share by Type (2016-2027)
    Figure 47. Latin America Diagnostic Nuclear Drug Market Share by Application (2016-2027)
    Figure 48. Latin America Diagnostic Nuclear Drug Market Share by Country (2016-2027)
    Figure 49. Mexico Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Diagnostic Nuclear Drug Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Diagnostic Nuclear Drug Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Diagnostic Nuclear Drug Market Share by Country (2016-2027)
    Figure 55. Turkey Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Bracco Imaging Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 59. Bayer Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 60. Curium Pharmaceuticals Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 61. Nordion Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 62. Triad Isotopes Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 63. Lantheus Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 64. GE Healthcare Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 65. China Isotope & Radiation Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 66. Jubilant Pharma Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 67. Eli Lilly Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 68. Novartis Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 69. SIEMENS Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 70. Dongcheng Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 71. Navidea Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
Frequently Asked Questions
Diagnostic Nuclear Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diagnostic Nuclear Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diagnostic Nuclear Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Artesunate Drugs

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quini ... Read More

Artesunate Medicines

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quini ... Read More

Desensitization

Desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is  ... Read More

Hypo-sensitization

Hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environm ... Read More